https://nxtin.health/2026/10/07/abl-diagnostics-becomes-abl-texcell-diagnostics/ 2026-10-07T14:27:11Z NXTin health en ABL Diagnostics becomes ABL Texcell diagnostics 2026-10-07T14:27:09Z Blog https://nxtin.health/2026/10/07/eurofins-completes-the-acquisition-of-element-materials-technologys-life-sciences-testing-services-business-in-north-america/ 2026-10-07T14:14:39Z NXTin health en Eurofins completes the acquisition of Element Materials Technology’s Life Sciences Testing Services business in North America 2026-10-07T14:14:36Z Blog https://nxtin.health/2026/10/07/launch-of-the-pilot-out-of-hospital-project-to-support-seniors-after-hospitalisation/ 2026-10-07T14:01:34Z NXTin health en Launch of the pilot “Out of Hospital” project to support seniors after hospitalisation 2026-10-07T14:01:31Z Blog https://nxtin.health/2026/10/07/we-took-lsd-out-of-the-binding-pocket-and-started-putting-new-molecules-in-jami-mandelin-on-kasvu-therapeutics-bet-on-depression/ 2026-10-07T11:06:25Z NXTin health en “We took LSD out of the binding pocket and started putting new molecules in”. Jami Mandelin on Kasvu Therapeutics’ bet on depression 2026-10-07T11:03:43Z Blog https://nxtin.health/2026/10/07/healthtech-2026-how-can-technology-help-deliver-healthcare-reform/ 2026-10-07T09:53:00Z NXTin health en HealthTech 2026: How can technology help deliver healthcare reform? 2026-10-07T09:52:57Z Blog https://nxtin.health/2026/10/07/new-partnership-to-give-patients-better-access-to-cell-therapy/ 2026-10-07T09:30:43Z NXTin health en New partnership to give patients better access to cell therapy 2026-10-07T09:30:40Z Blog https://nxtin.health/2026/10/07/a-majority-of-the-danish-council-of-ethics-recommends-abolishing-anonymity-in-egg-and-sperm-donation/ 2026-10-07T09:24:53Z NXTin health en A majority of the Danish Council of Ethics recommends abolishing anonymity in egg and sperm donation 2026-10-07T09:24:51Z Blog https://nxtin.health/2026/10/07/30-years-of-monitoring-shows-that-antibiotic-resistance-can-be-reduced/ 2026-10-07T09:16:24Z NXTin health en 30 Years of monitoring shows that antibiotic resistance can be reduced 2026-10-07T09:16:21Z Blog https://nxtin.health/2026/10/07/european-parliament-is-calling-the-european-commission-to-better-protect-workers-from-work-related-psychosocial-risks-and-stress/ 2026-10-07T08:30:03Z NXTin health en European Parliament is calling the European Commission to better protect workers from work-related psychosocial risks and stress 2026-10-07T08:30:00Z Blog https://nxtin.health/2026/10/07/vytenis-andriukaitis-to-discuss-the-european-biotech-act-at-lsmu/ 2026-10-07T09:02:58Z NXTin health en Vytenis Andriukaitis to discuss the European Biotech act at LSMU 2026-10-07T08:01:08Z Blog https://nxtin.health/2026/10/07/sensible-biotechnologies-secures-47m-to-advance-naturally-modified-mrna-platform-and-unlock-next-generation-of-mrna-medicines/ 2026-10-07T06:50:41Z NXTin health en Sensible Biotechnologies secures $47M to advance naturally modified mRNA platform and unlock next generation of mRNA medicines 2026-10-07T06:50:38Z Blog https://nxtin.health/2026/10/07/nobel-prize-in-physiology-or-medicine-2026/ 2026-10-07T08:40:18Z NXTin health en Nobel Prize in Physiology or Medicine 2026 2026-10-07T05:53:58Z Blog https://nxtin.health/2026/10/06/flen-health-advances-ves-gel-toward-u-s-registration-for-diabetic-foot-ulcers/ 2026-10-07T14:35:34Z NXTin health en Flen Health advances VES Gel toward U.S. registration for diabetic foot ulcers 2026-10-06T14:28:44Z Blog https://nxtin.health/2026/10/06/angelini-ventures-and-eib-co-lead-58m-series-a-financing-in-rouge-therapeutics-to-advance-first-in-class-treatment-for-hereditary-hemorrhagic-telangiectasia/ 2026-10-06T11:32:40Z NXTin health en Angelini Ventures and EIB co-lead $58M series A financing in Rouge Therapeutics to advance first-in-class treatment for hereditary hemorrhagic telangiectasia 2026-10-06T11:32:38Z Blog https://nxtin.health/2026/10/06/dont-miss-a-major-conference-on-first-line-of-defence-healthcare-and-pharmaceuticals-for-national-resilience/ 2026-10-06T13:26:56Z NXTin health en Don’t miss! A major conference “First Line of Defence: Healthcare and Pharmaceuticals for National Resilience” 2026-10-06T11:12:35Z Blog https://nxtin.health/2026/10/06/professor-dan-reinstein-joins-cornea-sense-as-clinical-and-strategic-advisor/ 2026-10-06T09:49:15Z NXTin health en Professor Dan Reinstein joins Cornea Sense as clinical and strategic advisor 2026-10-06T09:47:21Z Blog https://nxtin.health/2026/10/06/archeon-medical-secures-e7-5m-series-a-to-advance-clinical-validation-of-ventilation-system-for-cardiac-arrest-patients/ 2026-10-06T09:42:13Z NXTin health en Archeon Medical secures €7.5M Series A to advance clinical validation of ventilation system for cardiac arrest patients 2026-10-06T07:23:05Z Blog https://nxtin.health/2026/10/06/new-stereotactic-linear-accelerator-starts-operating-at-university-clinical-hospital-mostar/ 2026-10-06T06:40:10Z NXTin health en New stereotactic linear accelerator starts operating at University Clinical Hospital Mostar 2026-10-06T06:40:07Z Blog https://nxtin.health/2026/10/06/pitch-deck-blitz-or-trusted-relationships-johanna-asklin-on-what-every-innovator-should-know-about-vc/ 2026-10-05T14:14:45Z NXTin health en Pitch-deck blitz or trusted relationships? Johanna Asklin on what every innovator should know about VC 2026-10-06T02:09:00Z Blog https://nxtin.health/2026/10/05/invitation-to-join-the-economic-delegation-to-swiss-biotech-day-2027/ 2026-10-05T16:08:57Z NXTin health en Invitation to join the Economic delegation to Swiss Biotech Day 2027 2026-10-05T16:08:55Z Blog https://nxtin.health/2026/10/05/slovak-surgeons-perform-complex-robotic-cancer-surgery-on-patient-weighing-almost-160-kg/ 2026-10-05T15:58:10Z NXTin health en Slovak surgeons perform complex robotic cancer surgery on patient weighing almost 160 kg 2026-10-05T15:58:07Z Blog https://nxtin.health/2026/10/05/evonik-e80m-biotechnology-expansion/ 2026-10-05T15:42:24Z NXTin health en Evonik: €80M biotechnology expansion 2026-10-05T15:41:24Z Blog https://nxtin.health/2026/10/05/poprad-hospital-completes-e50-million-modernisation/ 2026-10-05T15:26:00Z NXTin health en Poprad Hospital completes €50 million modernisation 2026-10-05T15:21:45Z Blog https://nxtin.health/2026/10/05/future-hospital-2026-estonia-looks-to-the-next-generation-of-healthcare/ 2026-10-05T14:04:26Z NXTin health en Future Hospital 2026: Estonia looks to the next generation of healthcare 2026-10-05T14:04:22Z Blog https://nxtin.health/2026/10/05/taltech-publishes-the-first-estonian-language-digital-health-textbook/ 2026-10-05T13:50:08Z NXTin health en TalTech publishes the first Estonian-language Digital Health textbook 2026-10-05T13:49:10Z Blog https://nxtin.health/2026/10/05/estonia-expands-access-to-medicines-for-adhd-and-rare-diseases/ 2026-10-05T13:42:03Z NXTin health en Estonia expands access to medicines for ADHD and rare diseases 2026-10-05T13:25:26Z Blog https://nxtin.health/2026/10/05/swiss-market-seminar-for-healthtech-and-biotech-sector/ 2026-10-05T13:24:42Z NXTin health en Swiss market seminar for HealthTech and BioTech sector 2026-10-05T12:55:50Z Blog https://nxtin.health/2026/10/05/the-waiting-room-is-on-its-way-out-medon-is-taking-the-doctor-visit-online/ 2026-10-05T12:47:13Z NXTin health en The waiting room is on its way out: Medon is taking the doctor visit online 2026-10-05T12:43:32Z Blog https://nxtin.health/2026/10/05/anacardio-raises-e62-5m-financing-to-advance-transformational-novel-therapy-in-heart-failure-towards-phase-3-readiness/ 2026-10-05T09:53:15Z NXTin health en AnaCardio raises €62.5M financing to advance transformational novel therapy in heart failure towards Phase 3 readiness 2026-10-05T09:46:07Z Blog